Anil Sood

44PUBLICATIONS
265CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|Jun 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

|May 15, 2026
DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High-Grade Serous Ovarian Carcinoma.

|May 11, 2026
Rethinking depression diagnosis in ovarian cancer: The role of somatic symptoms.

|Jan 13, 2026
Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights.

Allison L Brodsky, Amma Asare, Bryan Fellman

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

Pageof 8

Frequent Collaborators

10 joint publications

Jinsong Liu

8 joint publications

Shannon Neville Westin

6 joint publications

Amir A Jazaeri

5 joint publications

Nicole D Fleming